Original Research

Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system

Psota M, Psenkova MB, Racekova N, Ramirez de Arellano A, Vandebrouck T, Hunt B

ClinicoEconomics and Outcomes Research 2017, 9:749-762

Published Date: 12 December 2017